Join
Live feed
·
PRReleasevia Quantisnow
Adaptive Biotechnologies Corporation logo
NeoGenomics Inc. logo

Adaptive Biotechnologies and NeoGenomics Partner to Expand Access to Personalized Disease Monitoring for Blood Cancer Patients

ByQuantisnow·Wall Street's wire, on your screen.
ADPT· Adaptive Biotechnologies CorporationNEO· NeoGenomics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ADPT (Adaptive Biotechnologies Corporation), NEO (NeoGenomics Inc.) and more on Quantisnow.